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ABSTRACT 
Most human diseases have been shown to have a genetic basis that is linked to regulation of gene expression at 
the transcriptional or post-transcriptional level. In the central dogma of biology, deoxyribonucleic acid (DNA)  
is transcribed to messenger ribonucleic acid (mRNA), and then translated into proteins; dysfunction in any of 
these processes may contribute to the development of disease. Sources of such potential irregularities include, 
but not limited to, the following: point mutations in DNA sequences, copy number alterations (CNAs) and 
abnormal mRNA and microRNAs (miRNAs) expression. MiRNAs are a type of non-coding RNA that inhibit 
the transcription and/or translation of specific target mRNAs. Current technologies allow the identification of 
biomarkers and study of the complex interplay between DNA, mRNA, miRNA and phenotypic variation. This 
thesis aims to tackle the statistical challenges that have arisen with the application of these technologies to 
investigate various genomic and transcriptomic alterations. 
In study I, modified least-variant set normalization for miRNA microarray, a new algorithm and software were 
developed for microRNA array data normalization. The algorithm selects miRNAs with the least array-to-array 
variation as the reference set for normalization. The selection process was refined by accounting for the 
considerable differences in variances between probes. Data are provided to show that this algorithm results in 
better operating characteristics than other methods.   
In study II, joint estimation of isoform expression and isoform-specific read distribution using multi-sample 
RNA-Seq data, a joint model and software were developed to estimate isoform-specific read distribution and 
gene isoform expression, using RNA-sequencing data from multiple samples. Observation of similarities in the 
shape of the read distributions solves the problem that the non-uniform read intensity pattern is not identifiable 
from the data provided by one sample.  
In study III, integrated molecular portrait of non-small cell lung cancers, molecular markers at the DNA, mRNA 
and miRNA level that can distinguish between different histopathological subtypes of non-small cell lung 
cancer were identified. Additionally, using integrated genomic data including CNAs and mRNA and miRNA 
expression data, three potential driver genes were identified in non-small cell lung cancer, namely MRPS22, 
NDRG1 and RNF7. Furthermore, a potential driver miRNA, hsa-miR-944, was identified. 
In study IV, integration of somatic mutation, expression and functional data reveals potential driver genes 
predictive of breast cancer survival. An analytic pipeline to process large-scale whole-genome and 
transcriptome sequencing data was created, and an integrative approach based on network enrichment analyses 
to combine information across different types of omics data was proposed to identify putative cancer driver 
genes. Analysis of 60 patients with breast cancer provided evidence that patients carrying more mutated 
potential driver genes had poorer survival. 
